sercloremine (cgp-4718a), usually as the hydrochloride salt, is a drug which was developed in the 1980s and was formerly under investigation as an antidepressant, but was never marketed. it acts as a selective, reversible inhibitor of monoamine oxidase a (rima) and serotonin reuptake inhibitor.